Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-060586

Co-Chief Executive Officer sold 440 shares at $4.92 ($2,165)

  • Co-Chief Executive Officer acquired 1,734 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Glickman Mark A · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-06 Exercise or conversion : show line 1 in the form +1,734 1,734 D
2022-12-06 Sale : show line 2 in the form −440 $4.92 $2,165 1,294 D
Open-market sales · 440 sh · avg $4.92 · $2,165

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-06 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,734 3,466 D
Loading xslF345X03/doc4.xml…